|
|
||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||



* Department of Dermatology and Allergy, Friedrich-Wilhelms-University of Bonn, Bonn, Germany;
Institute of Genetics, Friedrich-Wilhelms-University of Bonn, Bonn, Germany;
National Institute for Longevity Sciences, National Center for Geriatrics and Gerontology, Aichi, Japan; and
Institute for Medical Microbiology, Immunology, and Hygiene, Technical University of Munich, Munich, Germany
Tryptophan catabolism through IDO activity can cause nonresponsiveness and tolerance acting on T cells. Given the crucial importance of dendritic cells (DCs) in the initiation of a T cell response, surprisingly little is known about the impact of IDO activity and tryptophan deprivation on DCs themselves. In the present study, we show that human DCs differentiated under low-tryptophan conditions acquire strong tolerogenic capacity. This effect is associated with a markedly decreased Ag uptake as well as the down-regulation of costimulatory molecules (CD40, CD80). In contrast, the inhibitory receptors ILT3 and ILT4 are significantly increased. Functionally, tryptophan-deprived DCs show a reduced capacity to stimulate T cells, which can be restored by blockade of ILT3. Moreover, ILT3highILT4high DCs lead to the induction of CD4+CD25+ Foxp3+ T regulatory cells with suppressive activity from CD4+CD25– T cells. The generation of ILT3highILT4high DCs with tolerogenic properties by tryptophan deprivation is linked to a stress response pathway mediated by the GCN2 kinase. These results demonstrate that tryptophan degradation establishes a regulatory microenvironment for DCs, enabling these cells to induce T regulatory cells. The impact of IDO thus extends beyond local immune suppression to a systemic control of the immune response.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was supported by a grant from the Deutsche Forschungsgemeinschaft (SFB 704/TP A15) and BONFOR.
2 T.B. and D.v.B. contributed equally to this study.
3 Address correspondence and reprint requests to Dr. Dagmar von Bubnoff, Department of Dermatology and Allergy, Friedrich-Wilhelms-University of Bonn, Sigmund-Freud-Strasse 25, 53105 Bonn, Germany. E-mail address: d.bubnoff{at}uni-bonn.de
4 Abbreviations used in this paper: DC, dendritic cell; 7-AAD, 7-aminoactinomycin D; CHOP, C/EBP-homologous protein; iDC, immature DC; ILT, Ig-like transcript; mDC, mature DC; MFI, median fluorescence intensity; poly(I:C), polyriboinosinic-polyribocytidylic acid; rFI, relative fluorescence index; Treg, regulatory T cell; Trp, tryptophan; TT, tetanus toxoid.
5 The online version of this article contains supplemental material.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |